SCIE期刊PULMONARY PHARMACOLOGY & THERAPEUTICS 2024/2025影响因子:3.384 (PULM PHARMACOL THER) (1094-5539). (RESPIRATORY SYSTEM)

显示全部楼层 · 发表于 2025-3-26 21:30:04

Submitted on: 29 January 2006. Revised on: 11 March 2006. Accepted on: 03 April 2006. PULMONARY PHARMACOLOGY & THERAPEUTICS

显示全部楼层 · 发表于 2025-3-27 03:02:32

显示全部楼层 · 发表于 2025-3-27 05:59:14

Submitted on: 29 June 2022. Revised on: 09 July 2022. Accepted on: 26 July 2022. PULMONARY PHARMACOLOGY & THERAPEUTICS

显示全部楼层 · 发表于 2025-3-27 13:11:57

Submitted on: 07 November 2012. Revised on: 14 December 2012. Accepted on: 06 January 2013. PULMONARY PHARMACOLOGY & THERAPEUTICS

显示全部楼层 · 发表于 2025-3-27 17:31:30

Submitted on: 20 March 2010. Revised on: 10 April 2010. Accepted on: 28 April 2010. PULMONARY PHARMACOLOGY & THERAPEUTICS

显示全部楼层 · 发表于 2025-3-27 20:27:35

Submitted on: 22 April 1999. Revised on: 02 June 1999. Accepted on: 10 June 1999. PULMONARY PHARMACOLOGY & THERAPEUTICS

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-26 23:19
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved